CA2992961A1 - Systeme et procede de mesure d'icp - Google Patents
Systeme et procede de mesure d'icp Download PDFInfo
- Publication number
- CA2992961A1 CA2992961A1 CA2992961A CA2992961A CA2992961A1 CA 2992961 A1 CA2992961 A1 CA 2992961A1 CA 2992961 A CA2992961 A CA 2992961A CA 2992961 A CA2992961 A CA 2992961A CA 2992961 A1 CA2992961 A1 CA 2992961A1
- Authority
- CA
- Canada
- Prior art keywords
- energy
- acoustic signals
- amplitude
- spectral density
- intracranial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims description 27
- 238000007917 intracranial administration Methods 0.000 claims abstract description 43
- 230000003595 spectral effect Effects 0.000 claims abstract description 29
- 239000012530 fluid Substances 0.000 claims description 16
- 230000004044 response Effects 0.000 claims description 6
- 230000009466 transformation Effects 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 238000012886 linear function Methods 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 description 21
- 210000004556 brain Anatomy 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 230000017531 blood circulation Effects 0.000 description 14
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 14
- 230000008859 change Effects 0.000 description 12
- 238000012545 processing Methods 0.000 description 12
- 206010022773 Intracranial pressure increased Diseases 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 201000009941 intracranial hypertension Diseases 0.000 description 9
- 210000003128 head Anatomy 0.000 description 8
- 238000013459 approach Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 206010002329 Aneurysm Diseases 0.000 description 5
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 description 5
- 230000002159 abnormal effect Effects 0.000 description 5
- 210000001367 artery Anatomy 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 230000000737 periodic effect Effects 0.000 description 5
- 210000005013 brain tissue Anatomy 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 206010019196 Head injury Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000030886 Traumatic Brain injury Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000000739 chaotic effect Effects 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 210000000613 ear canal Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 230000036387 respiratory rate Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 230000009529 traumatic brain injury Effects 0.000 description 3
- 101100135641 Caenorhabditis elegans par-3 gene Proteins 0.000 description 2
- 101100489581 Caenorhabditis elegans par-5 gene Proteins 0.000 description 2
- 206010011732 Cyst Diseases 0.000 description 2
- 206010018852 Haematoma Diseases 0.000 description 2
- 208000018127 Idiopathic intracranial hypertension Diseases 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- 101100406879 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) par-2 gene Proteins 0.000 description 2
- 102100040853 PRKC apoptosis WT1 regulator protein Human genes 0.000 description 2
- 101710162991 PRKC apoptosis WT1 regulator protein Proteins 0.000 description 2
- 206010047139 Vasoconstriction Diseases 0.000 description 2
- 206010047163 Vasospasm Diseases 0.000 description 2
- 230000004872 arterial blood pressure Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 210000004004 carotid artery internal Anatomy 0.000 description 2
- 230000003727 cerebral blood flow Effects 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 208000031513 cyst Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000003906 hydrocephalus Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001114 myogenic effect Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 230000001272 neurogenic effect Effects 0.000 description 2
- 230000000926 neurological effect Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 208000001381 pseudotumor cerebri Diseases 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 210000003625 skull Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- 230000025033 vasoconstriction Effects 0.000 description 2
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 101100203377 Bacillus subtilis (strain 168) slp gene Proteins 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 101100242529 Drosophila melanogaster Pal2 gene Proteins 0.000 description 1
- 206010020591 Hypercapnia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 101150012565 LRIT1 gene Proteins 0.000 description 1
- 101100477497 Mus musculus Shcbp1 gene Proteins 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 206010062243 Shunt malfunction Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 230000003788 cerebral perfusion Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000001951 dura mater Anatomy 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 229940124645 emergency medicine Drugs 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 208000007386 hepatic encephalopathy Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000003284 homeostatic effect Effects 0.000 description 1
- 208000018875 hypoxemia Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000002464 muscle smooth vascular Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 201000003077 normal pressure hydrocephalus Diseases 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 101150077062 pal gene Proteins 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 210000004560 pineal gland Anatomy 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 208000005809 status epilepticus Diseases 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 210000002330 subarachnoid space Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/03—Measuring fluid pressure within the body other than blood pressure, e.g. cerebral pressure ; Measuring pressure in body tissues or organs
- A61B5/031—Intracranial pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/03—Measuring fluid pressure within the body other than blood pressure, e.g. cerebral pressure ; Measuring pressure in body tissues or organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B7/00—Instruments for auscultation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0204—Acoustic sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6814—Head
- A61B5/6815—Ear
- A61B5/6817—Ear canal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7253—Details of waveform analysis characterised by using transforms
- A61B5/7257—Details of waveform analysis characterised by using transforms using Fourier transforms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Neurosurgery (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562195370P | 2015-07-22 | 2015-07-22 | |
| US62/195,370 | 2015-07-22 | ||
| PCT/IL2016/050794 WO2017013655A1 (fr) | 2015-07-22 | 2016-07-21 | Système et procédé de mesure d'icp |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2992961A1 true CA2992961A1 (fr) | 2017-01-26 |
Family
ID=57834018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2992961A Abandoned CA2992961A1 (fr) | 2015-07-22 | 2016-07-21 | Systeme et procede de mesure d'icp |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP3324841A1 (fr) |
| CN (1) | CN107949322A (fr) |
| CA (1) | CA2992961A1 (fr) |
| WO (1) | WO2017013655A1 (fr) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11076797B2 (en) | 2018-04-10 | 2021-08-03 | Cerenetex, Inc. | Systems and methods for the identification of medical conditions, and determination of appropriate therapies, by passively detecting acoustic signals from cerebral vasculature |
| US12004846B2 (en) | 2018-04-10 | 2024-06-11 | Cerenetex, Inc. | Non-invasive systems and methods for the improved evaluation of patients suffering from undiagnosed headaches |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019160939A2 (fr) * | 2018-02-13 | 2019-08-22 | Barnacka Anna | Système à biocapteurs d'infrasons et procédé associé |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5792072A (en) * | 1994-06-06 | 1998-08-11 | University Of Washington | System and method for measuring acoustic reflectance |
| US5919144A (en) * | 1997-05-06 | 1999-07-06 | Active Signal Technologies, Inc. | Apparatus and method for measurement of intracranial pressure with lower frequencies of acoustic signal |
| WO2001050944A2 (fr) * | 2000-01-07 | 2001-07-19 | Rice Creek Medical, L.L.C. | Procede et dispositif non vulnerants de surveillance de la pression intracranienne |
| EP2010047A2 (fr) * | 2006-04-03 | 2009-01-07 | Mimosa Acoustics, Inc. | Procédé et système de surveillance de pression intracrânienne |
| EP2624747A1 (fr) * | 2010-10-08 | 2013-08-14 | Headsense Medical Ltd. | Appareil et procédé pour mesurer une pression intracrânienne |
-
2016
- 2016-07-21 EP EP16827367.0A patent/EP3324841A1/fr not_active Withdrawn
- 2016-07-21 CN CN201680051488.8A patent/CN107949322A/zh not_active Withdrawn
- 2016-07-21 WO PCT/IL2016/050794 patent/WO2017013655A1/fr not_active Ceased
- 2016-07-21 CA CA2992961A patent/CA2992961A1/fr not_active Abandoned
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11076797B2 (en) | 2018-04-10 | 2021-08-03 | Cerenetex, Inc. | Systems and methods for the identification of medical conditions, and determination of appropriate therapies, by passively detecting acoustic signals from cerebral vasculature |
| US12004846B2 (en) | 2018-04-10 | 2024-06-11 | Cerenetex, Inc. | Non-invasive systems and methods for the improved evaluation of patients suffering from undiagnosed headaches |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3324841A1 (fr) | 2018-05-30 |
| WO2017013655A1 (fr) | 2017-01-26 |
| CN107949322A (zh) | 2018-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5841605B2 (ja) | 頭蓋内圧を測定する装置と方法 | |
| CN106793952B (zh) | 用于颅内压力的测量的设备和方法 | |
| US9888884B2 (en) | Method of sonifying signals obtained from a living subject | |
| JP2017523889A (ja) | 頭蓋内圧の亢進を検出する装置および方法 | |
| EP3352675B1 (fr) | Appareil de détection de l'augmentation du gonflement cérébral et/ou d'un changement cérébral | |
| JP6547054B1 (ja) | 医療機器及びプログラム | |
| JP2020516358A (ja) | 対象を評価するための非侵襲的静脈波形解析 | |
| US20210267539A1 (en) | Systems and methods for processing sonified brain signals | |
| Şentürk et al. | Towards wearable blood pressure measurement systems from biosignals: a review | |
| CA2992961A1 (fr) | Systeme et procede de mesure d'icp | |
| JP7287612B2 (ja) | 生体情報取得装置 | |
| Traboulsi et al. | Transmission of infrasonic pressure waves from cerebrospinal to intralabyrinthine fluids through the human cochlear aqueduct: Non-invasive measurements with otoacoustic emissions | |
| CN111345791B (zh) | 一种脉搏波测量装置 | |
| KR101869881B1 (ko) | 스마트폰 유비쿼터스 헬스퀘어 진단시스템 및 그 제어 방법 | |
| Dhar et al. | Non-invasive ICP monitoring by auditory system measurements | |
| US20170319126A1 (en) | Method, apparatus and computer program product for examination of intra-uterus condition of a fetus | |
| Bieber et al. | Visual detection of short-wave blood pressure fluctuations | |
| Kaur | Methods for Continuous Non-invasive Measurement of Blood Pressure: Pulse Transit Time a Review | |
| Anchan | Estimating pulse wave velocity using mobile phone sensors | |
| KR20190019093A (ko) | 두개 내압 추정방법 및 두개 내압 추정장치 | |
| US20240099592A1 (en) | Monitoring of breathing and heart function | |
| RU2199946C2 (ru) | Способ диагностики вида и степени выраженности вегетативных нарушений у пациентов с тяжелой черепно-мозговой травмой | |
| Hernandez | An investigation of systemic haemodynamic correlates of intracranial pressure | |
| JP2018183550A (ja) | 予防管理支援装置及びシステム | |
| Kumar et al. | Detection of the Human Stress Response to Auditory Noise |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20200831 |